Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.
Flannick J; Thorleifsson G; Beer NL; Jacobs SB; Grarup N; Burtt NP; Mahajan A; Fuchsberger C; Atzmon G; Benediktsson R; Blangero J; Bowden DW; Brandslund I; Brosnan J; Burslem F; Chambers J; Cho YS; Christensen C; Douglas DA; Duggirala R; Dymek Z; Farjoun Y; Fennell T; Fontanillas P; Forsén T; Gabriel S; Glaser B; Gudbjartsson DF; Hanis C; Hansen T; Hreidarsson AB; Hveem K; Ingelsson E; Isomaa B; Johansson S; Jørgensen T; Jørgensen ME; Kathiresan S; Kong A; Kooner J; Kravic J; Laakso M; Lee JY; Lind L; Lindgren CM; Linneberg A; Masson G; Meitinger T; Mohlke KL; Molven A; Morris AP; Potluri S; Rauramaa R; Ribel-Madsen R; Richard AM; Rolph T; Salomaa V; Segrè AV; Skärstrand H; Steinthorsdottir V; Stringham HM; Sulem P; Tai ES; Teo YY; Teslovich T; Thorsteinsdottir U; Trimmer JK; Tuomi T; Tuomilehto J; Vaziri-Sani F; Voight BF; Wilson JG; Boehnke M; McCarthy MI; Njølstad PR; Pedersen O; Groop L; Cox DR; Stefansson K; Altshuler D; Nature Genetics, 2014, vol. 46, issue 4, p 357, ISSN 15461718. ISBN 15461718.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef